Jason Fredette | executive |
Martin Huber | executive |
Brian DeSchuytner | executive |
Jonathan Chang | analyst |
Colleen Hanley | analyst |
Ashiq Mubarack | analyst |
Kaveri Pohlman | analyst |
Boris Peaker | analyst |
Karina Rabayeva | analyst |
Good morning, and welcome to the Mersana Therapeutics Third Quarter 2023 Conference Call and Webcast. [Operator Instructions] Please note, this call is being recorded. I would now like to turn the call over to Jason Fredette, Senior Vice President, Investor Relations and Corporate Communications. Please go ahead.
Thank you, operator, and good morning, everyone.